|
| Press Releases |
|
 |
|
| Friday, August 28, 2020 |
|
|
Sino Biopharm Announces 2020 Interim Results |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced its unaudited interim results for the six months ended 30 June 2020 (the "review period"). more info >> |
|
| Thursday, May 28, 2020 |
|
|
Sino Biopharmaceutical Announces 2020 First Quarterly Results |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2020 ("the review period"). more info >> |
|
| Tuesday, May 26, 2020 |
|
|
New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration |
| Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced that the new drug application of the anti PD-1 monoclonal antibody drug more info >> |
|
| Tuesday, May 19, 2020 |
|
|
Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting |
| Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced that the abstracts on phase II study on clinical efficacy and safety of Penpulimab more info >> |
|
| Monday, March 30, 2020 |
|
|
Sino Biopharm Announces 2019 Annual Results |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX: 1177), a leading, innovative research and development driven pharmaceutical conglomerate in the PRC, has announced its financial results for the year ended 31 December 2019 ("the year"). more info >> |
|
| Tuesday, January 21, 2020 |
|
|
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO |
| Novotech CRO the largest biotech CRO in the Asia-Pacific said the region has had a record year for number of studies, experienced world-class sites and investigators, and patient enrolment. more info >> |
|
| Tuesday, November 26, 2019 |
|
|
Sino Biopharmaceutical Announces 2019 Third Quarterly Results |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited third quarterly results for the nine months ended 30 September 2019 ("the review period"). more info >> |
|
| Thursday, August 29, 2019 |
|
|
Sino Biopharmaceutical Announces 2019 Interim Results |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced today its unaudited interim results for the six months ended 30 June 2019 (the "review period").
more info >> |
|
| Wednesday, May 22, 2019 |
|
|
Sino Biopharmaceutical Announces 2019 First Quarterly Results |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2019 ("the review period").
more info >> |
|
| Monday, April 1, 2019 |
|
|
Sino Biopharmaceutical's 2018 Annual Results Reaches New Height |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its annual results for the year ended 31 December 2018.
more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Fourth Star's FSTR Token now Available on CoinMarketCap 
Feb 11, 2025 14:06 HKT/SGT
|
|
|
An Incredible KLAS Triple-Award Win for AGFA HealthCare!
Feb 11, 2025 14:02 HKT/SGT
|
|
|
Venturi Partners invests USD 25M in footwear brand JQR
Feb 11, 2025 10:20 HKT/SGT
|
|
|
GTJAI Participated in First Batch of Northbound Bond Connect Offshore RMB Repurchase Business on Launch Day
Feb 10, 2025 18:58 HKT/SGT
|
|
|
Move Digital Leads AI Revolution in 2025, Expands High-Level Consulting for Family Offices Worldwide
Feb 10, 2025 18:00 HKT/SGT
|
|
|
uSMART Capital, LLC officially approved for U.S. FINRA license
Feb 10, 2025 17:04 HKT/SGT
|
|
|
NEC Solution Modernizes Network Infrastructure Construction Work
Feb 10, 2025 15:05 JST
|
|
|
Renewable Energy Power Purchase Agreements: Analyzing, Structuring, and Negotiating for Bankable Green Investments in Competitive Markets
Feb 10, 2025 13:00 HKT/SGT
|
|
|
Olympus Recognized on CDP's "A List", the Highest Rating in the Field of Climate Change
Feb 10, 2025 11:00 JST
|
|
|
EVCharge Live Thailand 2025 to showcase the future of electric mobility on 26-27 February at BITEC, Bangkok
Feb 10, 2025 09:44 HKT/SGT
|
|
|
foundit Appoints V Suresh as Chief Executive Officer
Feb 10, 2025 09:00 HKT/SGT
|
|
|
Hola Prime Launches Transformative CSR Initiatives to Support Education, Health, and Sustainability
Feb 8, 2025 07:00 HKT/SGT
|
|
|
uSMART Capital, LLC officially approved for U.S. FINRA license
Feb 7, 2025 17:40 JST
|
|
|
TANAKA to Provide Medals for the Tokyo Marathon 2025 That Represent All the Participants in the Event with Woven Lines
Feb 7, 2025 4:00 JST
|
|
|
U.S.-Based Blockchain Kadena and Croatian Football Federation (HNS) Partner to Revolutionize Fan Engagement
Feb 6, 2025 23:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
